Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?

BACKGROUND Rifamycins are a group of antibiotics mainly used in the treatment of tuberculosis (TB), however they interact with antiretroviral therapy (ART). Rifabutin allows more regimens options for concomitant imunodeficiency virus (HIV) treatment compared to rifampicin. OBJECTIVE Compare the o...

Full description

Bibliographic Details
Main Authors: Carolina Arana Stanis Schmaltz, Fernanda de Oliveira Demitto, Flavia Marinho Sant’Anna, Valeria Cavalcanti Rolla
Format: Article
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2019-02-01
Series:Memórias do Instituto Oswaldo Cruz.
Subjects:
tuberculosis
HIV
rifampicin
rifabutin
rifamycin
outcomes
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762019000100312&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762019000100312&lng=en&tlng=en

Similar Items